Remove Clinical Development Remove Drug Trials Remove Drugs
article thumbnail

Small Pharma stock market launch funds DMT-based depression drug trial

pharmaphorum

DMT is a powerful hallucinogenic drug found in several plants including the South American plant chacruna and when used recreationally is mixed with the ayahuasca plant to make the shamanic brew of the same name. The goal of the trial is for proof of concept of the drug as a wrap-around therapy for Major Depressive Disorder.

article thumbnail

Avacta opens two US sites and doses first patient in sarcoma drug trial

Outsourcing Pharma

TWO US clinical investigator sites have been opened for a phase 1 clinical trial for patients with soft tissue sarcoma and the first patient has been dosed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unlocking the potential in rare disease research with decentralised trials

pharmaphorum

When asked about features of decentralised trial designs that people found most attractive, the top reasons given were the convenience of having more of the study take place at home and less time traveling, as well as the use of technology, both to communicate with research staff and to have their health monitored. Conclusion.

Trials 133
article thumbnail

Crucial Data Solutions Announces Updates to TrialKit AI, EHR to EDC API

Crucial Data Soutions

(CDS), a leading technology provider focused on data collection and clinical trial management, today announced several updates in celebration of its tenth anniversary, including the company’s latest technological development, TrialKit AI, a machine-learning API. 888) 753-4777 carley.nolan@crucialdatasolutions.com.

article thumbnail

Building Inclusive Trials: Insights from CTTI’s Diversity Initiatives

XTalks

A significant initiative is the Diversity Convergence project, which brings together multiple organizations, including the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, FasterCures, a center of the Milken Institute and the National Academies’ Forum on Drug Discovery, Development and Translation.

Trials 52
article thumbnail

Scepticism in press over Kintor’s COVID-19 US drug trial

pharmaphorum

China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. Reuters quoted Kintor’s chief financial officer Lucy Lu, who said that Kayali was one of its trial investigators.

article thumbnail

Steps to building a more patient-centric industry

pharmaphorum

As the industry focuses on creating a more holistic, inclusive patient experience, here are key steps to consider in order to help bridge the gap between clinical research and the patient experience. The fact is, many minorities never learn about vital clinical trials in play, or that they’re eligible to participate.